Align Technology, Inc. (ALGN)

FairStock Score: 58/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses whose economics are durable and whose price leaves room for error. Align has a real franchise: Invisalign clear aligners and iTero scanners are embedded in orthodontic workflows, and that creates switching friction. But the filed numbers show a maturing business. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $1.1B and net income $108.3M; in fiscal Q1 2026, revenue was $1.0B and net income $112.8M. FY2025 revenue was $4.0B with net income $410.4M and diluted EPS $5.65, essentially flat versus FY2024 revenue of $4.0B, net income $421.4M, and EPS $5.62. The FairStock Lynch category is slow grower/shrinking, citing profit -25.4% a year over five years, and the supplied profit growth is -13.09%. The balance sheet is a strength: D/E 0.03, Altman Z 3.98, Piotroski 6/9, and TTM FCF $633.6M gives a 5.9% FCF yield. Returns are only moderate, with ROE 10.15% and ROCE 7.56%. At the 2026-10-26 close of $152.26, FairStock shows P/E 26.39, P/B 2.56, EV/EBITDA 11.02, Graham Number $87.82 and margin of safety -75.94%. That is not a Graham bargain. I would want either clearer profit recovery or a lower price before calling it compelling.

In plain English: Align Technology makes Invisalign clear aligners and dental scanners. It is profitable and has very little debt, but sales growth is modest and profits have slipped recently. At the latest price, the shares look expensive compared with the company's current earnings and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer